510(k) K192774

BioCardia 8F Morph DNA Deflectable Guide Catheter by Biocardia — Product Code DQY

K192774 is an FDA 510(k) premarket notification submitted by Biocardia for the device "BioCardia 8F Morph DNA Deflectable Guide Catheter". The FDA issued a decision of Substantially Equivalent on January 7, 2020. The device falls under product code DQY (Catheter, Percutaneous), a Class II device regulated under 21 CFR 870.1250. Biocardia has at least 5 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 7, 2020
Date Received
September 30, 2019
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Catheter, Percutaneous
Device Class
Class II
Regulation Number
870.1250
Review Panel
CV
Submission Type